UnitedHealth Group (NYSE:UNH) Upgraded at Erste Group Bank
by Teresa Graham · The Cerbat GemUnitedHealth Group (NYSE:UNH – Get Free Report) was upgraded by Erste Group Bank from a “hold” rating to a “buy” rating in a report issued on Monday.
Several other analysts also recently commented on the company. Sanford C. Bernstein upped their price objective on UnitedHealth Group from $405.00 to $411.00 and gave the company an “outperform” rating in a research note on Tuesday, April 7th. TD Cowen upped their price objective on UnitedHealth Group from $311.00 to $337.00 and gave the company a “hold” rating in a research note on Thursday. HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price objective for the company in a research note on Tuesday, April 7th. Mizuho reduced their price objective on UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating for the company in a research note on Thursday, February 5th. Finally, Argus upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 price target for the company in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus price target of $377.64.
Read Our Latest Analysis on UnitedHealth Group
UnitedHealth Group Stock Performance
Shares of NYSE UNH traded down $4.16 during trading hours on Monday, reaching $350.76. The stock had a trading volume of 640,693 shares, compared to its average volume of 9,580,172. The firm has a market cap of $318.56 billion, a price-to-earnings ratio of 26.55, a PEG ratio of 1.53 and a beta of 0.40. The company has a current ratio of 0.80, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. UnitedHealth Group has a fifty-two week low of $234.60 and a fifty-two week high of $424.12. The firm has a 50-day moving average of $293.40 and a 200-day moving average of $316.63.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.76 by $0.47. The firm had revenue of $111.65 billion during the quarter, compared to analysts’ expectations of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The business’s revenue was up 2.0% on a year-over-year basis. During the same period in the prior year, the firm earned $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Equities research analysts predict that UnitedHealth Group will post 18.29 earnings per share for the current year.
Hedge Funds Weigh In On UnitedHealth Group
Several hedge funds and other institutional investors have recently made changes to their positions in UNH. Brighton Jones LLC lifted its holdings in shares of UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after acquiring an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC grew its stake in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares in the last quarter. CMT Capital Markets Trading GmbH acquired a new stake in UnitedHealth Group during the 2nd quarter valued at approximately $340,000. Flow Traders U.S. LLC bought a new stake in shares of UnitedHealth Group in the 2nd quarter worth about $356,000. Finally, Jump Financial LLC bought a new stake in shares of UnitedHealth Group in the 2nd quarter worth about $377,000. Institutional investors and hedge funds own 87.86% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.